- Report
- November 2023
- 127 Pages
North America
From €1348EUR$1,500USD£1,170GBP
- Report
- March 2025
- 260 Pages
Middle East
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 260 Pages
Africa
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 210 Pages
Latin America
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 840 Pages
Asia Pacific
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 980 Pages
Europe
From €2607EUR$2,900USD£2,263GBP
- Report
- March 2025
- 1400 Pages
Global
From €4404EUR$4,900USD£3,823GBP
- Report
- March 2025
- 50 Pages
Kenya
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Nigeria
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Egypt
From €539EUR$600USD£468GBP
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Greece
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Finland
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Denmark
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Norway
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Austria
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Ireland
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Sweden
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Switzerland
From €539EUR$600USD£468GBP
- Report
- March 2025
- 50 Pages
Netherlands
From €539EUR$600USD£468GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more